Supplementary Figure 3A from Brivanib, a Dual FGF/VEGF Inhibitor, Is Active Both First and Second Line against Mouse Pancreatic Neuroendocrine Tumors Developing Adaptive/Evasive Resistance to VEGF Inhibition

Autor:	Douglas Hanahan, Ian B. Walters, Elizabeth Allen
Rok vydání:	2023
DOI:	10.1158/1078-0432.22443012
Popis:	PDF file - 198K
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35764167f82c17a41b2305fbd73f582d https://doi.org/10.1158/1078-0432.22443012 Zobrazit plný text záznamu